10 results on '"Gilner J"'
Search Results
2. PB1516 CT-001, a Novel Factor VIIa, Demonstrates Enhanced In Vitro Procoagulant Activity in Peripartum Patient Samples
- Author
-
Sim, D., primary, Hermiston, T., additional, Allen, T., additional, Bae, D., additional, Gilner, J., additional, Kim, S., additional, Lee, S., additional, Mallari, C., additional, and James, A., additional
- Published
- 2023
- Full Text
- View/download PDF
3. Pilot study of machine learning for detection of placenta accreta spectrum.
- Author
-
Zhang, Y., Ellestad, S. C., Gilner, J. B., Pyne, A., Boyd, B. K., Mazurowski, M. A., and Gatta, L. A.
- Subjects
MACHINE learning ,PLACENTA accreta ,AMNIOTIC liquid ,PLACENTA praevia ,ANATOMICAL planes - Abstract
This article discusses a pilot study that utilized machine learning to detect placenta accreta spectrum (PAS) using ultrasound images. The study involved a retrospective review of ultrasound studies conducted at a single referral center. The researchers used three algorithms to generate machine segmentation of the placenta, bladder, and uterus. The results showed that the machine learning models were able to segment the placenta accurately, but had lower accuracy for the bladder and uterus. The study highlights the potential of machine learning in diagnosing PAS and suggests further research to differentiate between normal and pathologically adherent placentas. [Extracted from the article]
- Published
- 2024
- Full Text
- View/download PDF
4. 27: Chagas disease screening in umbilical cord blood: an opportunity for prevention
- Author
-
Edwards, J., primary, Gilner, J., additional, Kurtzberg, J., additional, and Heine, R., additional
- Published
- 2015
- Full Text
- View/download PDF
5. CT-001, a novel fast-clearing factor VIIa, enhanced the hemostatic activity in postpartum samples.
- Author
-
Sim DS, Mallari CR, Hermiston TW, Bae D, Lee S, Allen T, Gilner J, Kim SC, and James AH
- Subjects
- Female, Humans, Pregnancy, Blood Coagulation Factors, Factor VIIa pharmacology, Postpartum Period, Thrombin, Tomography, X-Ray Computed, Hemostatics pharmacology, Postpartum Hemorrhage
- Abstract
Abstract: The hemostatic system is upregulated to protect pregnant mothers from hemorrhage during childbirth. Studies of the details just before and after delivery, however, are lacking. Recombinant factor VIIa (rFVIIa) has recently been granted approval by the European Medicines Agency for the treatment of postpartum hemorrhage (PPH). A next-generation molecule, CT-001, is being developed as a potentially safer and more efficacious rFVIIa-based therapy. We sought to evaluate the peripartum hemostatic status of pregnant women and assess the ex vivo hemostatic activity of rFVIIa and CT-001 in peripartum blood samples. Pregnant women from 2 study sites were enrolled in this prospective observational study. Baseline blood samples were collected up to 3 days before delivery. Postdelivery samples were collected 45 (±15) minutes after delivery. Between the 2 time points, soluble fibrin monomer and D-dimer increased whereas tissue factor, FVIII, FV, and fibrinogen decreased. Interestingly, the postdelivery lag time and time to peak in the thrombin generation assay were shortened, and the peak thrombin generation capacity was maintained despite the reduced levels of coagulation proteins after delivery. Furthermore, both rFVIIa and CT-001 were effective in enhancing clotting activity of postdelivery samples in activated partial thromboplastin time, prothrombin time, thrombin generation, and viscoelastic hemostatic assays, with CT-001 demonstrating greater activity. In conclusion, despite apparent ongoing consumption of coagulation factors at the time of delivery, thrombin output was maintained. Both rFVIIa and CT-001 enhanced the upregulated hemostatic activity in postdelivery samples, and consistent with previous studies comparing CT-001 and rFVIIa in vitro and in in vivo, CT-001 demonstrated greater activity than rFVIIa., (© 2024 by The American Society of Hematology. Licensed under Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International (CC BY-NC-ND 4.0), permitting only noncommercial, nonderivative use with attribution. All other rights reserved.)
- Published
- 2024
- Full Text
- View/download PDF
6. Universal Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Testing for Obstetric Inpatient Units Across the United States.
- Author
-
Gilner J, Kansal N, Biggio JR, Delaney S, Grotegut CA, Hardy E, Hirshberg A, Kachikis A, LaCourse SM, Martin J, Metz TD, Miller ES, Norton ME, Sinkey R, Sobhani NC, Son SL, Srinivas S, Tita A, Werner EF, and Hughes BL
- Subjects
- COVID-19 Testing, Clinical Laboratory Techniques, Cross-Sectional Studies, Female, Humans, Inpatients, Pregnancy, SARS-CoV-2, United States epidemiology, COVID-19 diagnosis, COVID-19 epidemiology, Pregnancy Complications, Infectious diagnosis, Pregnancy Complications, Infectious epidemiology
- Abstract
Background: The purpose of this study was to estimate prevalence of asymptomatic severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection among patients admitted to obstetric inpatient units throughout the United States as detected by universal screening. We sought to describe the relationship between obstetric inpatient asymptomatic infection rates and publicly available surrounding community infection rates., Methods: A cross-sectional study in which medical centers reported rates of positive SARS-CoV-2 testing in asymptomatic pregnant and immediate postpartum patients over a 1-3-month time span in 2020. Publicly reported SARS-CoV-2 case rates from the relevant county and state for each center were collected from the COVID Act Now dashboard and the COVID Tracking Project for correlation analysis., Results: Data were collected from 9 health centers, encompassing 18 hospitals. Participating health centers were located in Alabama, California, Illinois, Louisiana, New Jersey, North Carolina, Pennsylvania, Rhode Island, Utah, and Washington State. Each hospital had an active policy for universal SARS-CoV-2 testing on obstetric inpatient units. A total of 10 147 SARS-CoV-2 tests were administered, of which 124 were positive (1.2%). Positivity rates varied by site, ranging from 0-3.2%. While SARS-CoV-2 infection rates were lower in asymptomatic obstetric inpatient groups than the surrounding communities, there was a positive correlation between positivity rates in obstetric inpatient units and their surrounding county (P=.003, r=.782) and state (P=.007, r=.708)., Conclusions: Given the correlation between community and obstetric inpatient rates, the necessity of SARS-CoV-2-related healthcare resource utilization in obstetric inpatient units may be best informed by surrounding community infection rates., (© The Author(s) 2021. Published by Oxford University Press for the Infectious Diseases Society of America. All rights reserved. For permissions, e-mail: journals.permissions@oup.com.)
- Published
- 2022
- Full Text
- View/download PDF
7. Anesthetic management of placenta accreta spectrum at an academic center and a comparison of the combined spinal epidural with the double catheter technique: A retrospective study.
- Author
-
Herbert KA, Gatta LA, Fuller M, Grotegut CA, Gilner J, and Habib AS
- Subjects
- Catheters, Female, Humans, Hysterectomy adverse effects, Pregnancy, Retrospective Studies, Anesthesia, Epidural adverse effects, Anesthetics, Placenta Accreta surgery
- Abstract
Study Objectives: To describe the anesthetic management and outcomes of placenta accreta spectrum (PAS) cases at our institution over a 19 year period and to compare outcomes associated with the lumbar combined spinal epidural (CSE) technique versus the double catheter technique (lumbar CSE with thoracic epidural catheter)., Design: Retrospective cohort study., Setting: Labor and delivery unit at a tertiary care center., Patients: 113 female patients who had histologically confirmed PAS on the final pathology report after cesarean delivery or cesarean hysterectomy., Intervention: Neuraxial anesthesia, including CSE and the double catheter technique, and general anesthesia for PAS cases (including scheduled and unscheduled cases and those known or unknown as PAS preoperatively)., Measurements: The medical records were reviewed for demographic information, intraoperative management, anesthetic technique, and outcomes. We describe anesthetic management and outcomes of cases classified as scheduled vs. unscheduled and known vs. unknown PAS. We also compare the CSE and double catheter techniques with the primary outcome being conversion to general anesthesia (GA)., Main Results: We included 113 cases: 60 (53.1%) scheduled/known cases, 12 (10.6%), scheduled/unknown cases, 22 (19.5%) unscheduled/known, and 19 (16.8%) unscheduled/unknown cases. All scheduled cases except two were started with a neuraxial technique. General anesthesia (GA) was used to start 18/41 (44%) of unscheduled cases. The double catheter technique (n = 35) was associated with a lower GA conversion rate (5.7% vs. 29.7%, P = 0.036) compared to the CSE technique (n = 37)., Conclusions: Neuraxial anesthesia is the most commonly used technique for PAS cases in our practice. The double catheter technique was associated with lower GA conversion rates compared to the CSE technique in our cohort., (Copyright © 2021 Elsevier Inc. All rights reserved.)
- Published
- 2022
- Full Text
- View/download PDF
8. High-risk third trimester pregnancy with decompensated cirrhosis safely delivered following emergent preoperative interventional radiology for mitigation of variceal bleeding.
- Author
-
Park C, Patel YA, Suhocki P, Dorsey C, Kapila N, Tang L, and Gilner J
- Subjects
- Female, Gastrointestinal Hemorrhage diagnostic imaging, Gastrointestinal Hemorrhage therapy, Humans, Liver Cirrhosis complications, Liver Cirrhosis diagnostic imaging, Pregnancy, Pregnancy Trimester, Third, Radiology, Interventional, Treatment Outcome, Esophageal and Gastric Varices complications, Esophageal and Gastric Varices diagnostic imaging, Esophageal and Gastric Varices therapy, Portasystemic Shunt, Transjugular Intrahepatic
- Abstract
Coagulopathy coupled with severe portal hypertension in the setting of cirrhosis increases the risk of mortality from variceal bleeding in pregnant women. Studies suggest transjugular intrahepatic portosystemic shunt (TIPS) creation to be a safe procedure during pregnancy in preventing variceal bleeding complications; however, it is not typically employed in severely decompensated cirrhosis. This case report of a pregnant woman presenting at 34.7 weeks' gestation demonstrates successful variceal mapping, emergent TIPS creation and variceal embolization to allow safe cesarean delivery despite severe hypofibrinogenemia and decompensated alcoholic cirrhosis. With careful medical optimization, angiographic imaging and vascular interventional radiology may be employed outside of usual indications to achieve safe pregnancy delivery and postpartum recovery., (Copyright © 2020. Published by Elsevier Inc.)
- Published
- 2020
- Full Text
- View/download PDF
9. Blood-Conservation Strategies in a Blood-Refusal Parturient with Placenta Previa and Placenta Percreta.
- Author
-
Mauritz AA, Dominguez JE, Guinn NR, Gilner J, and Habib AS
- Subjects
- Adult, Erythropoietin administration & dosage, Female, Hemodilution methods, Humans, Iron-Dextran Complex administration & dosage, Jehovah's Witnesses, Pregnancy, Tranexamic Acid administration & dosage, Treatment Outcome, Uterine Artery Embolization methods, Bloodless Medical and Surgical Procedures methods, Combined Modality Therapy methods, Placenta Accreta therapy, Placenta Previa therapy
- Abstract
Abnormal placentation can be associated with significant blood loss and massive blood transfusions. Caring for parturients with abnormal placentation who refuse blood transfusion is very challenging. We present a 35-year-old, gravida 3, para 1, Jehovah's Witness at 35 weeks of gestation with placenta percreta, who underwent cesarean delivery and delayed hysterectomy. A multidisciplinary team developed a plan, including the use of perioperative erythropoietin and IV iron dextran, intraoperative acute normovolemic hemodilution, cell salvage, tranexamic acid, and uterine artery embolization. This strategy was successful in avoiding the need for allogeneic transfusion and ensuring an uneventful recovery after both surgical procedures.
- Published
- 2016
- Full Text
- View/download PDF
10. Management of Short Cervix during Pregnancy: A Review.
- Author
-
Gilner J and Biggio J
- Subjects
- Administration, Intravaginal, Cerclage, Cervical, Cervical Length Measurement, Female, Humans, Infant, Newborn, Pessaries, Pregnancy, Pregnancy, Multiple, Progesterone administration & dosage, Cervix Uteri abnormalities, Cervix Uteri diagnostic imaging, Premature Birth etiology, Premature Birth prevention & control
- Abstract
Sonographic evaluation of the uterine cervix has evolved as one of the best clinical tools available for the prediction of subsequent spontaneous preterm birth (PTB), particularly when combined with prior poor obstetric history. There is a growing body of evidence describing interventions for short cervix that reduce the risk of preterm delivery and improve neonatal outcomes. Yet, given the significant heterogeneity in the pathways that lead to PTB, understanding the specific clinical characteristics of women who may benefit from a given intervention is critical to appropriate implementation. The three primary management strategies that have demonstrated improvement in obstetric and/or perinatal outcomes for appropriately selected women with a sonographically short cervix (vaginal progesterone, cervical cerclage, and pessary) are the subject of this review. In addition, the unique considerations of multiple pregnancies are discussed separately from singletons., (Thieme Medical Publishers 333 Seventh Avenue, New York, NY 10001, USA.)
- Published
- 2016
- Full Text
- View/download PDF
Catalog
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.